ArriVent BioPharma (NASDAQ:AVBP) Now Covered by Jefferies Financial Group

Analysts at Jefferies Financial Group initiated coverage on shares of ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat reports. The firm set a “buy” rating and a $35.00 price target on the stock. Jefferies Financial Group’s target price suggests a potential upside of 76.06% […]

Related Keywords

Arrivent Biopharma ,Analysts At Jefferies Financial Group ,Orbimed Advisors Llc ,Securities Exchange Commission ,Goldman Sachs Group ,Jefferies Financial Group ,Arrivent Biopharma Company Profile ,Arrivent Biopharma Inc ,Citigroup ,Get Free Report ,Financial Group ,Hillhouse Investment Managemen ,Exchange Commission ,Director Orbimed Advisors Llc ,Vent Biopharma ,Arrivent Biopharma Daily ,Nasdaq Avbp ,Avbp ,Medical ,Initiated Coverage ,Jefferies Financial Group Inc ,